Clinical trial
Piracetam for Treatment Tardive Dyskinesia
NCT00190008 · Beersheva Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00190008 |
|---|---|
| Title | Piracetam for Treatment Tardive Dyskinesia |
| Official title | Therapeutic Use of Piracetam for Treatment of Patients Suffering From Tardive Dyskinesia: a Double Blind, Placebo-Controlled Crossover Study |
| Lead sponsor | Beersheva Mental Health Center, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tardive Dyskinesia |
| Intervention type | Drug |
| Interventions | piracetam |
| Enrollment | 40 |
| Start date | Aug 1, 2003 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 25, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: